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RPE65 is a retinal pigment epithelial protein essential for the regeneration of 11-cis-retinal, the chromophore
of cone and rod visual pigments. Mutations in RPE65 lead to a spectrum of retinal dystrophies ranging from
Leber’s congenital amaurosis to autosomal recessive retinitis pigmentosa. One of the most frequent mis-
sense mutations is an amino acid substitution at position 91 (R91W). Affected patients have useful cone
vision in the first decade of life, but progressively lose sight during adolescence. We generated R91W
knock-in mice to understand the mechanism of retinal degeneration caused by this aberrant Rpe65 variant.
We found that in contrast to Rpe65 null mice, low but substantial levels of both RPE65 and 11-cis-retinal were
present. Whereas rod function was impaired already in young animals, cone function was less affected.
Rhodopsin metabolism and photoreceptor morphology were disturbed, leading to a progressive loss of
photoreceptor cells and retinal function. Thus, the consequences of the R91W mutation are clearly dis-
tinguishable from an Rpe65 null mutation as evidenced by the production of 11-cis-retinal and rhodopsin
as well as by less severe morphological and functional disturbances at early age. Taken together, the patho-
logy in R91W knock-in mice mimics many aspects of the corresponding human blinding disease. Therefore,
this mouse mutant provides a valuable animal model to test therapeutic concepts for patients affected by
RPE65 missense mutations.
INTRODUCTION
The vitamin A derivative 11-cis-retinal is the chromophore of
rod and cone visual pigments. Absorption of light leads to an
11-cis to all-trans isomerization followed by dissociation of
all-trans-retinal from the protein moiety (opsin) of the visual
pigment holo-complex. The regeneration of the visual chro-
mophore is a complex protein-mediated process termed the
visual cycle (1). The crucial all-trans to 11-cis-retinoid iso-
merization reaction step takes place in the retinal pigment epi-
thelium (RPE) and is catalyzed by RPE65 (2–4).
Rpe65-deficient mice lack 11-cis-retinal and consequently no
rhodopsin is detectable in their eyes (5,6). Instead, these
animals show in the RPE an over-accumulation of retinyl
esters, retinoid intermediates of the visual cycle (5).
More than 60 disease-associated mutations have been identi-
fied in the human RPE65 gene [summarized in http://www.
retina-international.com/sci-news/rpe65mut.htm; see also
Zernant et al. (7)]. The broad spectrum of mutations includes
point mutations, splice-site defects, deletions and insertions.
Mutations in RPE65 are estimated to account for 11% of
all autosomal recessive childhood-onset retinal dystrophy
cases (8). Patients suffering from mutations in the RPE65
gene are alternatively diagnosed as autosomal recessive retini-
tis pigmentosa, autosomal recessive retinal dystrophy,
early-onset severe retinal dystrophy (EOSRD) or Leber’s
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congenital amaurosis type II (LCAII) (8–10). These rather
diverse diagnoses reflect the phenotypic heterogeneity of the
underlying disease. Most patients suffering from mutations
in the RPE65 gene are diagnosed early in childhood as
severely visually impaired, with night blindness, distinctly
restricted visual fields and nystagmus, but no photophobia
(summarized in 11). Retinal function (ERG) is undetectable
after dark adaptation and is severely impaired following
light adaptation. However, many of these patients have suffi-
cient vision to attend elementary school. Vision is then gradu-
ally lost, resulting in blindness almost invariably in the third
decade of life (11).
Two naturally occurring models (rd12 mouse and Briard
dog) and the genetically engineered Rpe65 knock-out mouse
(Rpe652/2) have been useful for the delineation of RPE65
protein function in the visual cycle (5,12,13). These models
have meanwhile been used in pre-clinical gene replacement
therapy experiments to restore rod and cone photoreceptor
function [rd12 (14), Rpe652/2 (15–18), dog (19–22)]. All
of the above models represent a ‘null situation’ for RPE65,
in which the visual cycle has never been functional.
However, current literature indicates that more than 50% of
RPE65 mutations in patients are missense mutations. Some
of these missense mutations presumably produce mutant ver-
sions of RPE65 with some residual enzymatic activity.
Recently, we characterized three consanguineous families car-
rying the R91W mutation in RPE65 (23). All affected family
members had useful cone-mediated vision in the first decade
of life, suggesting that the mutant RPE65 protein is expressed
and possesses residual function. The consequences of a partial
loss of RPE65 activity caused by a missense mutation have not
yet been studied in an in vivo animal model and little is known
about the pathology of LCA/EOSRD under such conditions.
To assess this specific pathology, we generated the
Rpe65-R91W knock-in mouse as a model for the human
disease and analyzed the effect of the mutation on retinal func-
tion, visual cycle and morphology.
RESULTS
Generation of R91W knock-in mice
Gene targeting in mouse ES cells was used to modify exon 4
of the Rpe65 gene such that codon 91 changed from arginine
to tryptophan (R91W) (Fig. 1A). In humans, the R91W
mutation is caused by a single point mutation (TGA.TGG).
However, in mice, arginine 91 is encoded by a CGA codon;
therefore, two point mutations were introduced into codon
91 (CGA.TGG). The introduction of these two mutations
resulted in the loss of a TaqI restriction site, facilitating the
genotype analysis (Fig. 1A–C).
The gene targeting strategy is shown in Figure 1B. In
addition to mouse Rpe65 genomic DNA carrying the R91W
mutation, the targeting vector contained a floxed neo resist-
ance and a diphtheria toxin (DT) cassette as selection
markers. Sequencing of the full genomic DNA insert of the
targeting vector confirmed the presence of the R91W mutation
and the selection markers in an otherwise wild-type sequence
(Fig. 1A). The linearized construct was electroporated into
coisogenic TC1 ES cells, and correctly targeted ES cell
clones were identified and characterized in detail by Southern
blotting, PCR and PCR restriction digestion analysis (Fig. 1C;
data not shown).
These clones were used to generate germ-line competent
chimeric mice. A chimeric male was mated with coisogenic
129S6 females to propagate the line. The resulting heterozy-
gous (Rpe65R91Wneo) F1 mice were bred with a germ-line Cre-
deleter mouse line [129S6-Tg(Prnp-GFP/Cre)1Blw/J)] (24) to
excise the neo cassette (Fig. 1B). The resulting offspring was
heterozygous for the R91W mutation (R91W/wt). The only
foreign sequence in addition to the R91W substitution was a
single intronic loxP site. Finally, we interbred the heterozy-
gous R91W/wt mice to obtain pure homozygous 129S6/
SvEvTac-Rpe65tm1Lrcb (R91W) knock-in mice. Of note,
these mice were coisogenic to 129S6 control mice, except
for codon 91 and the above-mentioned loxP site.
Rpe65 expression in mutant mice
Quantitative RT–PCR, immunoblotting and immunohisto-
chemistry showed that the mutant protein is expressed in
R91W knock-in but not in Rpe652/2mice (Fig. 2A–C).
Whereas the expression of Rpe65 mRNA was only slightly
reduced in R91W mice (Fig. 2A), immunoblotting revealed
that the steady-state protein levels of the RPE65R91W mutant
variant were reduced by 95% when compared with wild-type
mice (Fig. 2B; data not shown). The mutant protein was
detected in the RPE and thus was correctly localized (Fig. 2C).
Lecithin retinol acyltransferase (LRAT) and cellular retinal-
dehyde binding protein (CRALBP) are functionally connected
to RPE65 and the visual cycle (25–28). Expression of both
proteins was comparable in eyecups of 8-week-old wild-type,
R91W knock-in and Rpe652/2 animals with a tendency of
increased LRAT levels in knock-out mice (Fig. 2B). Levels
of rod opsin were slightly reduced in retinas of R91W mice
and—as previously reported (5)—in retinas of Rpe652/2
animals.
Retinoid analysis
The absence of RPE65 results in the arrest of the visual cycle,
causing an accumulation of retinyl esters in the RPE and
visual chromophore deficiency (5). On the basis of this obser-
vation, we expected that the dramatically reduced protein
levels of the RPE65R91W variant (Fig. 2B) would also result
in a disturbance of the visual cycle. Therefore, we analyzed
the retinoid composition in dark-adapted wild-type, R91W/
wt heterozygous, R91W homozygous and Rpe652/2 mice at
different ages. HPLC analysis of whole eye preparations of
4, 8, 12, 24 and 40-week-old animals demonstrated the pre-
sence of 11-cis-retinal in R91W homozygous mice, though
at low levels between 2.5 and 6.3% when compared with age-
matched wild-type animals (Table 1). As expected, no
11-cis-retinal was detectable in Rpe652/2 mice at any age
(Table 1) (5,29). All-trans-retinal, all-trans-retinol and
9-cis-retinal levels were comparable between R91W and
Rpe652/2 mice. The retinoid content and composition in
R91W/wt heterozygous animals did not differ from wild-type
mice at all tested ages (Table 1).
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Figure 1. Generation of R91W knock-in mice. (A) Partial sequence of exon 4 wild-type and mutated R91W DNA. Note that two point mutations were introduced
in the codon for arginine (R) at position 91 to obtain tryptophan (W). This resulted in the loss of a TaqI restriction site in the mutated DNA (right panel).
Sequence data of the targeting vector showing the mutant TGG triplet at position 91 (left panel). (B) Schematic representation of the R91W targeting strategy
I: partial wild-type Rpe65 allele, with restriction enzyme sites and location of first six exons (boxes). II: targeting construct containing R91W mutation (indicated
as lost TaqI restriction site in mutated exon 4), neomycin (neo)-resistant gene flanked by loxP sites (indicated as triangles) suitable for cre-medated excision, and
diphtheria resistance cassette (DT). Note the unique XhoI restriction site used for linearization of the targeting vector. III: genomic Rpe65 DNA after integration
of targeting vector carrying the neomycin cassette (Rpe65R91Wneo). Positions of PCR primer pairs and Southern blot probe (gray box) for PCR are indicated.
Neo1 and neo2 are nested primer pairs designed to read from the selection cassette into the 30 short arm outside of targeting area. These primers were used
to confirm the HR. The Taq primer pair was used to confirm the presence of R91W mutation (see Materials and Methods). IV: the partial R91W mutant
allele after the removal of the neo cassette by crossing Rpe65R91Wneo mice with the Cre-deleter mice. (C) Genotyping of R91W mutants. Upper panel: DNA
was isolated from neomycin-resistant ES cell colonies and analyzed by Southern blotting, after digestion with EcoRI, and using 30external probe as indicated
in (B). Signal from the genomic DNA from wild-type (wt) allele is 5.6 kb. A heterozygous Rpe65R91Wneo knock-in (KI) allele gives rise to additional 7.7 kb due
to the presence of the neomycin cassette. Middle panel: PCR analysis of the same DNA using neo1 and neo2 nested primer pair. A PCR fragment of 1445 bp
detected in heterozygous Rpe65R91Wneo knock-in due to the presence of the neomycin cassette. Lower panel: RFLP-PCR analysis of the same DNA using the Taq
primer pair [see (B)]. A PCR fragment of 998 bp was digested with the TaqI restriction enzyme. In wild-type animals, this results in a 379 and a 619 bp fragment.
Heterozygous Rpe65R91Wneo knock-in DNA contains an additional 998 bp fragment due to the loss of the TaqI restriction site. This protocol was used for geno-
typing of the final R91W knock-in mice. Asterisk indicates mutated exon 4.
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The presence of 11-cis-retinal indicated that the visual cycle is
functional in R91W animals. Nevertheless, we detected a strong
and almost linear (13 pmol/day; R2 ¼ 0.93) accumulation of
retinyl esters during the first 24 weeks of life. Between 24 and
40 weeks, no further increase was detected (2186 and
2108 pmol/eye, respectively; Table 1) suggesting that a
plateau was reached in R91W mice. In Rpe652/2 animals
retinyl ester levels increased linearly (9 pmol/day; R2 ¼ 0.96)
throughout 40 weeks (Table 1). Electron microscopy revealed
that this accumulation of retinyl esters was accompanied by
the formation of lipid droplets in the RPE of R91W and, as pre-
viously reported, in Rpe652/2 mice (5) (Fig. 3).
Rhodopsin content and regeneration
We next determined dark-adapted rhodopsin levels, which
reached 30 pmol/retina (Fig. 4A) in R91W mice representing
6% of wild-type rhodopsin. This percentage was comparable
to the amount of 11-cis-retinal observed in 4-week-old
R91W mice, which corresponded likewise to 6% of wild-type
levels (Table 1).
The expression levels of RPE65 protein govern the kinetics
of rhodopsin regeneration (30,31). Given the reduced amount of
RPE65 in R91W mice (Fig. 2), we expected that rhodopsin
would regenerate with a much slower rate. To allow a
maximal rhodopsin production, we kept R91W mice in darkness
for 4, 10 and 22 days. By the time of analysis, the mice were 6–
7-weeks old. Maximal rhodopsin levels detected after 22 days in
darkness were 42 pmol, which was still ,10% of wild-type
animals (Fig. 4A; see Fig. 4C for the wild-type levels).
In order to test rhodopsin regeneration kinetics, 6–7-
week-old animals were dark-adapted for 24 h and exposed
for 10 min to 5000 lux, which bleaches 90% of rhodopsin in
Figure 2. R91W mutation causes reduced levels of RPE65. (A) Relative mRNA levels of Rpe65 expressed in eyecups of wild-type, R91W (homozygous),
Rpe652/2 and R91W/wt (heterozygous) mice at 8 weeks of age as determined by real-time RT–PCR. mRNA levels, normalized to b-actin, are expressed rela-
tive to wild-type control, which was set to 1. RNA isolated from three independent retinas per age and genotype was amplified in triplicates (means+SD).
(B) Western blotting of eyecup or retinal proteins from 8-week-old wild-type, R91W or Rpe652/2 mice. The presence of the R91W mutation resulted in
reduced amounts of RPE65 immunoreactivity. Note similar levels of LRAT and CRALBP in the eyecups of all strains with a tendency of increased LRAT
levels in Rpe652/2 mice. Slightly reduced amounts of rod opsin (Rho) were detected in retinas of mutant mice (asterisk indicates Rho monomer, dimer or
trimer, respectively). Shown are the representative blots from at least three different animals per genotype. (C) Immunolabeling with a polyclonal antibody
to RPE65, demonstrating that the RPE65R91W mutant protein is expressed only in RPE cells. Note the reduced immunoreactivity when compared with
animals expressing wild-type RPE65 protein. The Rpe652/2 animals served as negative controls.
Table 1. Retinoid analysis
Age 11-cis-retinal All-trans-retinal All-trans-retinol Retinyl ester 9-cis-retinal
Wild-type 4 380.2+60.1 39.0+11.3 4.2+3.6 30.6+5.6 n.d.
8 336.1+21.8 34.7+1.6 5.4+9.4 39.2+5.0 n.d.
12 336.7+32.4 62.6+12.9 n.d. 34.9+4.6 n.d.
24 373.6+75.5 47.9+3.7 2.2+3.8 106.2+27.2 n.d.
R91W/wt 4 394.7+22.6 53.4+7.1 6.0+0.8 44.3+5.4 n.d.
8 371.8+22.1 87.1+4.7 n.d. 55.7+8.4 3.7+0.3
12 454.8+42.0 52.4+5.5 3.0+3.7 89.6+17.9 n.d.
24 337.4+49.0 86.4+15.3 n.d. 108.9+23.3 n.d.
R91W 4 24.0+3.0 3.6+0.6 10.4+1.9 420.7+34.5 7.6+0.8
8 15.4+0.2 4.8+1.5 9.2+5.2 651.9+127.4 9.9+0.9
12 13.5+0.2 2.7+0.4 13.9+2.7 1542.7+271.8 9.2+1.2
24 9.4+8.2 1.9+1.7 20.2+17.7 2186.1+160.1 4.3+3.7
40 18.2+4.8 2.2+1.0 12.4+3.4 2107.9+138.9 10.6+3.2
Rpe652/2 4 n.d. n.d. 8.6+2.5 271.4+22.8 4.8+1.5
8 n.d. 1.3+1.2 5.4+1.0 474.9+49.1 8.5+0.7
12 n.d. 1.9+0.4 14.9+4.1 805.9+57.5 6.7+0.9
24 n.d. 2.1+0.3 8.5+4.8 1160.6+529.0 10.3+3.8
40 n.d. 2.8+1.0 15.6+5.1 2622.9+531.3 13.1+11.2
All values are given in pmol/eye+SD (n ¼ 3). Age in weeks, as indicated. n.d., not detectable.
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wild-type mice (27). Animals were returned to darkness to
allow regeneration of the visual pigment. Non-exposed
R91W mice contained 27 pmol of rhodopsin (Fig. 4B),
which was bleached by light exposure, reducing it to
1 pmol. Even after prolonged dark-adaptation (5 days) only
44% (12 pmol) of the pre-bleach value (27 pmol) was detect-
able. Thus, following a strong bleach, regeneration of rhodop-
sin was inefficient and reached a plateau at about half the
maximal level of non-bleached, dark-adapted animals.
Maximal dark-adapted rhodopsin levels were similar in
R91W/wt heterozygous (538 pmol/retina) and wild-type
(560 pmol/retina) (Fig. 4C). The calculated regeneration
rates following a strong bleach were 6.3 pmol/min in wild-
type and 4.9 pmol/min in R91W/wt mice, indicating slightly
slower rhodopsin regeneration kinetics in the heterozygous
situation.
Photoreceptor function in R91W mutant mice
Next, we studied the consequences of the reduced
11-cis-retinal levels on retinal function. Scotopic ERG
recordings revealed that higher flash intensities were
needed to induce an electrical response in R91W when com-
pared with wild-type mice (Fig. 5A, top panel). By assessing
the luminance required to generate a half maximal b-wave
amplitude (32), the reduction in light sensitivity in
8-week-old R91W mice was determined to be 2.5 log
units when compared with wild-type. Therefore, R91W
mice are about one log unit more sensitive to light than
Rpe652/2 animals (6). In age series testing of 8, 12, 24
and 40-week-old animals, the sensitivity threshold remained
unaltered, whereas the b-wave amplitude was reduced with
increasing age in R91W, this being especially prominent
between 12 and 24 weeks (Fig. 5A, top and bottom
panels). From 24 to 40 weeks of age, no further reduction
in b-wave amplitude was detected. Thus, the sensitivity of
the retina was not prone to age-related reduction, whereas
the maximal response size was.
In order to test cone function, ERG responses were recorded
under photopic conditions (Fig. 5B). Notably, there was no
difference in threshold sensitivity or in amplitude of the
b-wave between 8-week-old R91W and wild-type control
animals (Fig. 5B, top and bottom panels). Given the low
amount of chromophore available (Table 1), cone responses
should be somehow affected. In addition, the waveforms
were altered in a way similar to that observed in Rpe65 null
mice (6), indicating that rods are active under those con-
ditions. Therefore, it appears that the photopic signals are
mixed responses containing both rod and cone system
components.
A comparison of wild-type and R91W/wt heterozygous
animals resulted, as expected, in no difference between the
genotypes under scotopic or photopic conditions (data not
shown).
Figure 3. Lipid-like inclusions in R91W mice. Electron microscopy of the RPE-photoreceptor interface in 8-week-old wt, R91W/wt, R91W and Rpe652/2 mice.
Note that lipid-like inclusions (arrowheads) are present in R91W and Rpe652/2 mice only, and the better preservation of OS morphology in R91W mice when
compared with Rpe652/2.
Figure 4. Rhodopsin content and regeneration kinetics. (A) Rhodopsin levels
in 6–7-week-old R91W animals kept in darkness for 1 day or up to 22 days (as
indicated). (B) Rhodopsin regeneration of R91W and wild-type mice. Follow-
ing 24 h dark-adaptation, R91W mice were exposed to 5000 lux for 10 min
and the rhodopsin content was analyzed either immediately (i) or after differ-
ent periods of recovery in darkness (as indicated). Unexposed, dark-adapted
mice (d) served as controls. (C) Rhodopsin regeneration of wild-type and
R91W/wt heterozygous mice. Experimental protocol and abbreviations are
as in (B). Note the slightly slower regeneration kinetics in R91W/wt mice.
Filled squares, R91W/wt; open squares, wild-type. All values are given in
pmol/eye+SD. At least three animals per condition and genotype were ana-
lyzed.
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Assessment of retinal morphology
The results of the tests for retinal function, both scotopic and
photopic ERG responses, in R91W mice suggested an
age-related retinal degenerative process (Fig. 5). To analyze
the consequences of the R91W mutation on retinal mor-
phology, we compared the three different genotypes (wild-
type, R91W and Rpe652/2) at various ages (from 4 weeks
to 1 year; Fig. 6). Already at 4 weeks of age, the outer seg-
ments (OS) of R91W and Rpe652/2 mice showed signs of
disorganization (Fig. 6, top row). The reduced compactness
and shortening of OS became more obvious as mice grew
older. Although the thickness of the outer nuclear layer
(ONL) at earlier time-points was comparable with wild-type,
Figure 5. ERG responses to single-flash stimuli with increasing intensities in 8, 12, 24 and 40-week-old R91W and wild-type animals. (A) Scotopic single-flash
ERG intensity series indicating loss of sensitivity in mutant mice. (B) Photopic single-flash ERG intensity series reflecting a similar sensitivity of wild-type and
R91W animals at 8 weeks of age. Note the decline of the b-wave amplitude with increasing age. Upper panels in (A) and (B) are recordings from representative
animals for a given genotype and age and in lower panels group statistics are presented (n ¼ 3). Boxes in group statistic graphs indicate the 25 and 75% quantile
range, whiskers indicate the 5 and 95% quantile, and the black line connects the medians of the data.
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only five rows of nuclei remained in the central area of
1-year-old mutant animals, when compared with nine to 10
rows in 1-year-old wild-types. In comparison to Rpe652/2
animals, R91W mice showed a better preservation of OS, at
least up to 12 weeks of age (Fig. 6). Notably, R91W mice con-
tained more cone nuclei than respective age-matched
Rpe652/2 mice, particularly at early age.
At all ages, we found no differences between the retinal
morphology of wild-type and R91W/wt heterozygous mice
(data not shown), which is in line with a recessive inheritance
of the phenotype caused by the R91W mutation. Furthermore,
no morphological differences between genotypes were detect-
able in inner retinal structures upon examination by light
microscopy.
DISCUSSION
R91W knock-in mice phenocopy human disease
In humans, about half of the identified mutations in RPE65 are
missense mutations [http://www.retina-international.com/
sci-news/rpe65mut.htm; see also Zernant et al. (7)]. The
newly generated Rpe65 R91W knock-in mice represent the
analogous animal model to human patients carrying a mis-
sense mutation in RPE65. In patients, the different mutations
in RPE65 are associated with variable degrees of severity of
retinal dysfunction (10,33). This is likely explained by the
different functional consequences of these mutations. All pre-
sently available animal models, however, carry either null
mutations having no residual function or a variant (L450M)
which causes only a mild disturbance of the visual cycle
without retinal degeneration (34).
We found that the rod system in R91W knock-in mice is
severely desensitized, although not as much as in mice
lacking RPE65 (6). Cones, however, are better preserved
and appear to be functional at least in young animals. Simi-
larly, R91W patients diagnosed with EOSRD are typically
night-blind (desensitized rod system) but retain cone-mediated
vision in the first decade (23). Reports on patients carrying
other missense mutations in RPE65 demonstrate functional
cone vision early in life (summarized in 35). Another distinct
group of patients affected by RPE65 mutations is character-
ized as legally blind from birth or severely visually impaired
in infancy. These patients are diagnosed as LCAII. The corre-
sponding mouse model, Rpe652/2 mice, clearly has no cone
function, and the minimal residual visual function is due to
desensitized rods using isorhodopsin with 9-cis-retinal as a
chromophore (6,36). The R91W knock-in mice, like patients
suffering from EORSD, possess a phenotype clearly dis-
tinguishable from the null situation in both mice and
humans. Thus, our analysis suggests that for an understanding
of a particular disease, reproducing the real mutation is
superior to a ‘simple’ knock-out mouse model.
Metabolic changes induced by R91W mutation
Very recently, the role of RPE65 as the isomerohydrolase in
the visual cycle was demonstrated by studies in cell culture
systems (2–4,37). In these experiments, a minimal visual
cycle has been restored in cell lines different from RPE and
only cells transfected with RPE65 vectors produced 11-cis-
retinal from precursor molecules. Further studies using the
same experimental paradigm aimed at the understanding of
Figure 6. Light microscopic changes in R91W retinas in comparison to wild-
type and Rpe652/2 mice at various ages. Disorganization of OS was evident
in R91W mice already at 4 weeks and became more pronounced with aging.
By 8 weeks, more voids were visible in the ONL accompanied by the appear-
ance of pycnotic nuclei. By 1 year, only five to six rows of nuclei remained in
the ONL. When compared with Rpe652/2 mice, R91W mice showed better
retinal preservation (longer OS and higher density) and more cone nuclei
were visible in younger animals. RPE, retinal pigment epithelium; OS, outer
segments; IS, inner segments; ONL, outer nuclear layer; INL, inner nuclear
layer.
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the consequences caused by missense mutations in RPE65
related to human disease (4,38,39). In particular, a study on
RPE65R91W showed that this mutation causes decreased
protein levels due to a decreased protein stability and/or
protein mislocalization (39). Additionally, in this report no
isomerohydrolase activity of the RPE65R91W protein variant
was detected. To circumvent the limitations of the in vitro
cell culture system and to analyze the consequences of
RPE65 missense mutations in a more ‘natural’ environment,
Chen et al. (17) employed a different strategy: they delivered
mutant Rpe65 genes to the RPE of RPE65-deficient mice by
means of an adenoviral vector. This strategy reproduced the
results of the in vitro cell culture system. In particular, the
expression of Rpe65R91W did not result in detectable RPE65
immunostaining in the RPE and accordingly was not
accompanied by 11-cis-retinal production or a gain of retinal
function.
In contrast, R91W knock-in mice showed: (i) detectable
protein expression with a correct localization to the RPE and
(ii) metabolic activity as evidenced by the generation of
11-cis-retinal. Thus, not surprisingly, the in vivo situation rep-
resents the most accurate model to assess the consequences of
a mutation. This study also validates our hypothesis that the
RPE65 protein with an R91W amino acid substitution pos-
sesses residual activity in human patients.
R91W knock-in mice have an altered visual cycle
Like the wild-type protein, the mutant RPE65R91W was
detected exclusively in the RPE, but at highly reduced levels
(5% of wild-type levels). Since RNA levels were less affected
(240%), translational or post-translational mechanisms may
contribute to the reduction in the protein levels of the
RPE65R91W variant. Comparison of Rpe65 knock-out with
Rpe65 R91W knock-in mice revealed important differences
with regard to biochemical function, the most important one
being the limited, but measurable ability of R91W knock-in
mice to generate 11-cis-retinal. In order to form functional
rhodopsin, 11-cis-retinal has to be incorporated into rod
opsin. In wild-type mice, the levels of 11-cis-retinal and rod
opsin are linearly correlated (27). In R91W mice, rod opsin
was only slightly reduced in comparison to wild-type
animals (Fig. 2B). Thus, low amounts of rod opsin are not
the reason for reduced 11-cis-retinal and rhodopsin levels
(,10% of wild-type). Another limitation of the visual cycle
in R91W knock-in mice was revealed in bleaching exper-
iments. Wild-type mice recovered their rhodopsin within
1–3 h after a bleach (27,34). R91W mice did not recover rho-
dopsin to dark-adapted levels within days. Thus, in addition to
the limitation in rhodopsin production as outlined above, a
strong bleach impaired rhodopsin regeneration.
Our data suggest that large amounts of unliganded rod opsin
must be present in photoreceptors of R91W knock in mice,
despite the fact that R91W mice can produce 11-cis-retinal.
As 11-cis-retinal acts as an inverse agonist, its low availability
could cause increased spontaneous activity of the
chromophore-free opsin molecule, leading to a constitutive
activation of the phototransduction cascade (40,41). It has
been hypothesized that in the presence of unliganded opsin
the retina sends a signal that results in vitamin A uptake
from the circulation (26). Thus, an insufficient supply of
opsin with 11-cis-retinal in R91W mice may be the cause of
the observed accumulation of retinyl esters.
One might speculate that 11-cis-retinal in R91W mice does
not originate from RPE, but from the recently proposed cone
visual cycle (42). In this alternate pathway, the cone pigment
is regenerated in Mu¨ller glia cells, independently of the RPE.
Hypothetically, such a cone visual cycle could be less
affected, or even may be fully operational despite the
R91W mutation. But how would the rods acquire
11-cis-retinal under this condition? 11-cis-retinal is cova-
lently bound to rod opsin via a protonated Schiff base and
this binding is tight. The cone opsin/11-cis-retinal holo-
complex is less stable, and it has been recently shown to dis-
sociate spontaneously (43). Thus, 11-cis-retinal might be
‘stolen’ by rods from cones due to this spontaneous dis-
sociation of the visual chromophore. This scenario might
also explain why rhodopsin regeneration kinetics is ineffi-
cient. Even though RPE65 has been reported to be detected
in cones (44,45) and this disputed (6,46), there is no experi-
mental evidence that RPE65 is directly involved in the pro-
posed cone visual cycle. However, contradictory to this
hypothesis, almost equal amounts of 11-cis-retinal were
retained up to 40 weeks of age, the time when the cones in
R91W animals are almost completely lost (unpublished
data).
Retinal degeneration
Constant activation of the phototransduction cascade due to
chromophore starvation has been implicated in rod degene-
ration in Rpe652/2 mice and consequently rod degeneration
can be prevented by blocking rod specific G-protein transducin
(Gnat1) signaling (47). Nevertheless, Rpe652/2; Gnat12/2
double mutant animals accumulate similar amounts of
retinyl esters as Rpe652/2 mice, indicating that unliganded
opsin, and not the accumulation of retinyl esters, is the
primary cause of degeneration (47). This concept is reinforced
by the observation that systemic supplementation with
9-cis-retinal preserves photoreceptor structure, despite conti-
nuing accumulation of retinyl esters (26). Accordingly, a
better preservation and slower degeneration of retinal mor-
phology in R91W in comparison to Rpe652/2 animals
might be attributable to the presence of small amounts of
11-cis-retinal. Nevertheless, also in R91W mice, the photo-
transduction cascade may be permanently activated, finally
causing retinal degeneration. This possibility will be further
investigated in R91W; Gnat12/2 double mutant mice.
Conclusion
We generated a novel mouse model for retinal dystrophy
caused by a missense mutation in RPE65. There are striking
functional differences to the knock-out situation, which are
not only important for basic research but also for understand-
ing the pathology and for clinical diagnosis in patients. Fur-
thermore, our results indicate that the therapeutic window
for gene therapy—the first tests of which are being carried
out these very days—is likely to differ between patients with
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null and missense mutations. Thus, preclinical trials for gene
replacement are underway for the R91W knock-in mouse.
MATERIALS AND METHODS
Generation of R91W knock-in mice
A classical strategy using homologous recombination (HR) in
embryonic stem (ES) cells has been employed to replace the
wild-type with a modified Rpe65 allele; 13.3 kb of Rpe65
genomic DNA (derived from the 129/Sv mouse strain)
divided into two contiguous subclones: E1-12 containing
exons 1–3 and clone E2-8 containing exons 4–6 cloned into
EcoRI restriction site of pBluescriptII SK(2) vector were
kindly provided by M.T. Redmond (National Eye Institute,
Bethesda, USA) (48).
Clone E2-8 containing exon 4 served as template for the
PCR targeted site-directed mutagenesis. Two point mutations
were introduced into the mouse R91 codon (CGA . TGG)
using a respective reverse primer (C AGT CAT TGC CCA
AAC ATA AGC ATC AGT GCG GAT GAA TCT GAA
GAC TAT TGA GAA ATG GA; underlined codon denotes
position 91) to obtain the R91W mutation. The forward
primer (GCG CGT AAT ACG ACT CAC TA) was designed
to hybridize in the plasmid backbone. The presence of the
R91W mutation was confirmed by sequencing. The neomycin
(neo) resistance cassette flanked by loxP sites (floxed-neo) in
the direct repeat orientation was integrated into the NheI site
downstream exon 5. The 30 site of the vector was truncated
by BamHI digestion resulting in the creation of the short
arm of the targeting construct. In the final step, the DT cassette
was introduced at the 50 site of the vector (upstream of exon 1)
to serve as a negative selection marker. The final targeting
construct carrying the R91W mutation was sequenced.
The XhoI-linearized targeting vector was electroporated into
coisogenic TC1 ES cells derived from 129S6/SvEvTac
(129S6) mouse strain (49). Genomic DNA from G418-
resistant ES clones was analyzed for correct vector integration
by PCR and Southern blotting as described below.
The positive ES clones were injected into blastocysts origin-
ating from C57BL/6 mice to obtain chimeric mice. Two chi-
meric males were born. Germ-line transmission was
confirmed in one male. This was done by breeding the chi-
meric males with C57BL/6 females where positive selection
was performed by coat colour assessment and PCR genotyping
form tail genomic DNA using neo1, neo2 and Taq primer pairs
(Table 2).
Following the confirmation of germ-line transmission, the
chimeric male was bred to 129S6 females to propagate the
line on a coisogenic background. This breeding resulted in
the generation of a heterozygous Rpe65R91Wneo line. The geno-
type was confirmed by PCR using neo1, neo2 and Taq primer
pairs (Table 2).
For in vivo removal of the neo resistance cassette,
Rpe65R91Wneo mice were bred with deleter mice expressing
cre recombinase in their germ-line [129S6-Tg(Prnp-GFP/
Cre)1Blw/J (24)]. The Rpe65R91Wneo mice were kept on a cre-
deleter background for two generations to ensure complete
excision of the floxed-neo cassette. The deletion of the neo
cassette was confirmed by PCR genotyping using neo1, neo2
and cre primer pairs (Table 2). Finally, the resulting hetero-
zygous (R91W/wt) offspring was intercrossed to obtain
R91W homozygous mice. The R91W knock-in mice analyzed
herein were therefore on a coisogenic 129S6 background. The
genotyping of the final R91W knock-in mice was performed
by PCR on tail genomic DNA using the Taq primer pair as
described in Table 2.
Genotype assessment
DNA from G418-resistant ES cells was analyzed by Southern
blotting. An external 30 BamHI probe (759 bp) was random-
labeled using the DIG labeling kit (#1585614, Roche Diagnos-
tics, Mannheim, Germany). Genomic ES cell DNA was
digested overnight with EcoRI and electrophoresed on a
0.8% agarose gel. DNA samples were transferred onto a
nylon membrane by a capillary method. The membrane was
incubated with the DIG-labeled probe. Fragments correspond-
ing to wild-type and, knock-in alleles (5.6 and 7.7 kb, respect-
ively) were detected by enhanced chemiluminescence.
For the detection of the correctly integrated neo cassette,
two primer pairs have been selected to allow a nested PCR
approach (Table 2). For the neo1 primer pair, the forward
primer was designed within the neo cassette and the reverse
primer was positioned outside of the targeted DNA sequence.
To further minimize any false-positive result, a nested neo2
primer pair was created within the same area, thus only cor-
rectly integrated DNA should be detectable by PCR (Table 2).
A Taq primer pair (Table 2) was used to detect the presence
of the R91W mutation. This pair produced a 998 bp fragment
from both wild-type and mutant DNA. Only the wild-type
DNA amplicon included a TaqI restriction site, resulting in
619 and 379 bp fragments after incubation with TaqI restric-
tion enzyme.
Animals
All procedures concerning animals were in accordance with
the regulations of the Veterinary Authority of Zurich and
with the statement of ‘The Association for Research in
Vision and Ophthalmology’ for the use of animals in research.
All animals were raised in cyclic light (12:12 h; 60 lux at cage
level). The cre expressing mice 129S6-Tg(Prnp-GFP/
Cre)1Blw/J (24) and corresponding wild-type mice (129S6)
were purchased from the Jackson Laboratory (Bar Harbor,
USA). Rpe65 deficient mice (Rpe652/2) were maintained at
the University Hospital Zurich (5). Genotyping was performed
by PCR on tail genomic DNA, using the primers shown in
Table 2.
RNA isolation, reverse transcription and real-time PCR
RNA isolation and reverse transcription from eyecup tissue
were performed as previously described (50). cDNA quantifi-
cation was carried out by real-time PCR using the LightCycler
480 Sybr Green I Master kit and a LightCycler 480 instrument
(Roche). cDNAs were amplified with primers for Rpe65 and
b-actin described elsewhere (5,51), and normalization was
done using the DDCT (comparative threshold cycle) method.
Relative values were calculated using a suitable calibrator
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sample as indicated in the results. Three animals were ana-
lyzed per genotype and each reaction was run in triplicate.
Western blotting
The retina or the remaining eyecup tissue was separately iso-
lated and processed for immunoblotting as previously
described (27). The primary antibodies used were: rabbit
anti-RPE65 (pin5; 1:2000); mouse anti-LRAT (1:1000, gift
from K. Palczewski, University of Washington, Seattle,
USA); rabbit anti-CRALBP (UW55; 1:10 000, gift from
J.C. Saari, University of Washington, Seattle, USA); mouse
anti-Rho (4D2) (1:8000, gift from D. Hicks, Universite´
Louis Pasteur, Strasbourg, France) and b-actin as standard
(1: 1000, Santa Cruz, USA). At least three animals were ana-
lyzed per genotype.
Rhodopsin steady-state levels and rhodopsin
regeneration kinetics
Mice were dark adapted for 24 h, sacrificed under dim red
light, and retinas were isolated through a slit in the cornea.
Rhodopsin content was analyzed as described earlier (27).
The kinetics of rhodopsin regeneration after bleaching was
analyzed as previously described in detail (27). Briefly, mice
were dark adapted for 24 h and pupils were dilated 30–
60 min prior to light exposure. Animals were exposed for
10 min to 5000 lux of fluorescent white light. Following illu-
mination, mice were placed in darkness for the times indicated
in the results and rhodopsin content was analyzed as described
above. Non-exposed mice served as dark controls. At least
three animals were analyzed per condition and genotype.
Histology
Animals were sacrificed and the superior part of the eye was
marked for orientation. The enucleated eyes were fixed over-
night in 2.5% glutaraldehyde prepared in 0.1 M cacodylate
buffer and processed as described previously (50). Semi-thin
sections (0.5 mm) of Epon-embedded tissue were prepared
from the inferior central retina, counterstained with Methylene
blue and analyzed using a microscope (Axiovision, Zeiss,
Jena, Germany). For electron microscopy, thin sections were
analyzed using a Hitachi 7000 electron microscope (Hitachi,
Tokyo, Japan).
Immunofluorescence
Enucleated eyes were immersed in cryoprotective medium
(Jung, Nussloch, Germany) and processed for immunofluor-
escence as described recently (29). For detection, rabbit
anti-RPE65 primary antibody (1:500) and Cy3 conjugated
anti-rabbit secondary antibody (Jackson ImmunoResesarch,
Soham, UK) were applied. Immunofluorescence was analyzed
on a microscope (Axiovision, Zeiss) and documented using a
digital imaging system.
HPLC determination of retinoids
Mice were dark-adapted for 24 h. All steps were carried out
under dim red light. Animals were sacrificed, and lens and
vitreous were removed from the eye through a slit in the
cornea. The rest of the tissue including the retina and
eyecup was snap frozen in liquid nitrogen until further analy-
sis. Retinoid extraction and HPLC analysis was performed as
previously described (27).
ERG functional tests
ERGs were recorded binocularly according to previously
described procedures (6) in anesthetized mice with dilated
pupils using a Ganzfeld bowl, a DC amplifier and a
PC-based control and recording unit (Toennies Multiliner
Vision; Viasys Healthcare, Ho¨chberg, Germany). Recordings
were obtained in both scotopic (dark-adapted overnight) and
photopic (light-adapted 10 min at 30 cd s/m2) conditions.
Single white-flash stimulus intensity ranged from 24 to
1.5 log cd s/m2 under scotopic and from 22 to 4 log cd s/m2
under photopic conditions, divided into 10 and 13 steps,
respectively. Ten responses per intensity were averaged with
an inter-stimulus interval of either 5 or 17 s (.1 cd s/m2).
At least three animals per genotype and age were analyzed.
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